What is the Impact Factor of Blood Cells Molecules and Diseases?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Blood Cells Molecules and Diseases is 2.10, ranking in quartile Q3 of Web of Science (SCIE).

Is Blood Cells Molecules and Diseases indexed in Web of Science or Scopus?

Yes, Blood Cells Molecules and Diseases is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.852 (Q2) and an H-index of 105.

Who publishes Blood Cells Molecules and Diseases and what is the Article Processing Charge (APC)?

Blood Cells Molecules and Diseases is published by Academic Press Inc.. The estimated Article Processing Charge (APC) is approximately $3,118 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Blood Cells Molecules and Diseases?

The official ISO-4 abbreviation of Blood Cells Molecules and Diseases is "BLOOD CELL MOL DIS" with common acronym "bcmd". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #6,285Hybrid

Blood Cells Molecules and Diseases

Acronym:bcmd

•

Abbreviation (ISO):BLOOD CELL MOL DIS

•

Identifier (ISSN):1079-9796(Print)/1096-0961(Online)

•

Publisher:Academic Press Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↑ +0.4

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Blood Cells Molecules and Diseases

WoS Q3

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q2

0.852

#6,285

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

105

105 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate4.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

65articles/year

19.15% Gold OA•96.67% Original Research

Aims & Scope

Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.

Topics Covered (Recognized by AI)

Biology91.8%Medicine84.9%Genetics83.3%Chemistry78.2%Internal medicine77.4%Biochemistry76.1%Gene56.9%Immunology48.4%Pathology36.8%Cell biology32.8%Organic chemistry28.9%Psychology25%Physics23.1%Endocrinology21.9%Molecular biology21.7%Psychiatry21.3%

Primary Research Areas

Medicine Hematology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

HEMATOLOGY

Rank61/103

IndexSCIE

JCISCIE2026

HEMATOLOGY

Rank56/103

IndexSCIE

Category	Index	Rank	Quartile
HEMATOLOGY	JCRSCIE	61/103	Q3
HEMATOLOGY	JCISCIE	56/103	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.1

Articles / Year35

Total Citations6

2025

IF1.7

Articles / Year36

Total Citations37

2024

IF2.1

Articles / Year49

Total Citations191

2023

IF2.3

Articles / Year43

Total Citations263

2022

IF2.372

Articles / Year40

Total Citations194

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	35	6
2025	1.7	36	37
2024	2.1	49	191
2023	2.3	43	263
2022	2.372	40	194
2021	3.039	67	593
2020	2.46	92	1,058
2019	2.305	89	1,079
2018	1.836	61	923
2017	—	111	2,594
2016	—	137	2,324
2015	—	124	2,203

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,285Scopus Q2SCImago Profile

Scopus Coverage:1995-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q2

0.852

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.11

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,118 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations213

3-Year Documents107

Citable Documents92

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate49.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ2

Molecular BiologyQ2

Molecular MedicineQ2

Cell BiologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

3区HEMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Blood Cells Molecules and Diseases (acronym: bcmd, abbr: BLOOD CELL MOL DIS, ISSN: 1079-9796) is a peer-reviewed international scholarly journal in the field of Medicine, published by Academic Press Inc. in United States since 1995. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.852 (Q2), an H-index of 105.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 65 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,118 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.